Nuevo León will participate in two international studies to test the efficacy of the vaccine. Photo: AFP
MONTERREY, Nuevo Leon
In the struggle to discover the vaccine what fights the Covid-19, the state of New Lion will participate in two international studies to test the efficacy and safety of two products that develop China and Germany.
It may interest you: First experimental vaccines against Covid-19 are applied in Oaxaca
The above made it known, the Secretary of State Health, Manuel de la O Cavazos, who indicated that the first of the studies will be developed in the Zambrano Hellion Hospital by Tec Salud.
“It consists of a multicenter study to test the efficacy, safety and immunogenicity of the mRNA vaccine,” said the state official.
He detailed that the vaccine is developed by the CureVac laboratory in Germany, also, 2,500 people from Nuevo León will participate, although worldwide it is contemplated that there will be 27 thousand.
The second study is that of the chinese laboratory CanSinoBio vaccine, to be held at the Metropolitan Hospital. In this case, the participation of a thousand people is contemplated.
Copyright law strictly prohibits copying all or part of Excelsior’s materials without having previously obtained written permission and without including the link to the original text.